Ligand Pharmaceuticals, Inc. (LGND) Reports Q4 EPS of $0.19

February 13, 2013 4:18 PM EST
Get Alerts LGND Hot Sheet
Trade LGND Now!
Join SI Premium – FREE
Ligand Pharmaceuticals, Inc. (NASDAQ: LGND) reported Q4 EPS of $0.19, versus $0.22 reported last year. Revenue for the quarter came in at $13.6 million, versus $12.9 million reported last year.

For earnings history and earnings-related data on Ligand Pharmaceuticals, Inc. (LGND) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment